Welcome to our dedicated page for Veralto SEC filings (Ticker: VLTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Veralto's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Veralto's regulatory disclosures and financial reporting.
Jennifer Honeycutt, President, CEO and Director of Veralto Corporation (VLTO), reported option exercise and share sale transactions dated 08/29/2025. She exercised 10,646 fully vested employee stock options at an exercise price of $28.76 per share under a Rule 10b5-1 plan adopted May 28, 2025, resulting in 10,646 shares issued. The same 10,646 shares were sold the same day at $106.26 per share. After these transactions she beneficially owned 116,865 shares following the exercise and 106,219 shares following the sale. The options have an exercise window exercisable through 02/24/2027. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025.
Form 144 notice from Veralto Corporation (VLTO) indicates a proposed sale of 10,646 Common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $1,131,243.96. The filing shows the securities were acquired on 08/29/2025 as an option granted 02/24/2017, with payment recorded as cash. The number of shares outstanding is listed as 248,160,850. The scheduled approximate sale date is 08/29/2025. The form does not identify the specific individual or entity for whose account the shares will be sold, and there are no reported sales by this person in the past three months.
Veralto Corporation (VLTO) Q2 FY25 – Form 10-Q snapshot
- Revenue: $1.37 bn, +6.4% YoY; core growth 4.8%. Water Quality (WQ) +6.2% to $825 m; Product Quality & Innovation (PQI) +6.8% to $546 m.
- Profitability: Gross margin 60.0% (-10 bp YoY). Operating profit rose 4.7% to $313 m; WQ margin expanded to 25.6% while PQI margin softened slightly.
- Net earnings: $222 m vs $203 m; diluted EPS $0.89 (+9.9%). Effective tax rate fell to 22.1% from 24.8%.
- Cash flow & liquidity (six-month YTD): CFO $496 m (+35%); capex $31 m; ending cash $1.56 bn vs $1.10 bn at FY-24. Long-term debt $2.67 bn; net cash ≈ $(1.11) bn.
- Balance sheet strength: Equity up 30% YTD to $2.66 bn, aided by earnings and FX translation gains; AOCI loss narrowed to $(892) m.
- Mix & pricing: Recurring revenue ~61% YTD; price contributed ~1.7 pp to Q2 sales growth.
- Geography: Developed markets +7.0% (North America +6.3%, W. Europe +9.2%); High-growth markets +5.0%.
- Guidance & outlook: Management expects sustained demand in municipal/industrial water and steady CPG demand; monitoring macro, FX and tariff risks.